UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of April 2024
Commission File Number 001-37381
MEDIGUS LTD.
(Translation of registrant’s name into English)
10 HaNechoshet Street, Tel-Aviv, 6971072, Israel
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
EXPLANATORY NOTE
On April 9, 2024, Medigus Ltd. issued a press release titled: “Medigus Announces Corporate Rebranding Changes Name to Xylo Technologies Ltd. to Reflect Core Values of its Business.” A copy of this press release is furnished herewith as Exhibit 99.1.
1
EXHIBIT INDEX
| Exhibit | Description | |
| 99.1 | Press release dated April 9, 2024 |
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| MEDIGUS LTD. | ||
| Date: April 9, 2024 | By: | /s/ Tali Dinar |
| Tali Dinar | ||
| Chief Financial Officer | ||
3